Flow Cytometry Shared Resource Archives
Cell signaling targets in leukemia
Dec. 9, 2021—Vanderbilt researchers identified a critical role for IL-1beta signaling in leukemia cells with a certain mutation, suggesting this pathway may be a good target for novel treatments.
Discovery points to new cancer immunotherapy option
Feb. 21, 2019—An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer.
DISSECTing cell signaling networks
Dec. 14, 2015—Vanderbilt researchers have developed a new method to study cell signaling networks at single-cell resolution.
Photo: FlowSight
Aug. 2, 2012—Researchers in the Vanderbilt Flow Cytometry Shared Resource (FCSR) show off the new Amnis FlowSight, which provides an image of every single cell that passes through it and merges the capabilities of flow cytometry and fluorescent microscopy. From left are David Flaherty, lab manager, Kevin Weller, FCSR managing director, Core Research Assistant I Chris Warren...
